Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2026-01-01 @ 11:26 PM
Study NCT ID:
NCT05147558
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-26
First Post:
2021-11-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Pembrolizumab With Lenvatinib in Women With Advanced Uterine Carcinosarcoma
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-23
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12-23
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-23
Completion Date Type:
ESTIMATED
First Submit Date:
2021-11-15
First Submit QC Date:
None
Study First Post Date:
2021-12-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-25
Last Update Post Date:
2025-09-26
Last Update Post Date Type:
ESTIMATED